These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 1483486)
1. Effect of treatment at night with S-1452, a thromboxane A2 receptor antagonist, on the morning rise in platelet aggregation. Fujimura A; Kumagai K; Ohashi K; Ebihara A Eur J Clin Pharmacol; 1992; 43(5):501-5. PubMed ID: 1483486 [TBL] [Abstract][Full Text] [Related]
2. Effect of food intake on pharmacokinetics and effects of a new thromboxane A2 receptor antagonist, S-1452. Fujimura A; Shiga T; Kumagai Y; Ohashi K; Ebihara A; Kotegawa T Eur J Clin Pharmacol; 1996; 50(4):311-4. PubMed ID: 8803525 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of a new thromboxane A2 receptor antagonist, S-1452, and its effect on platelet aggregation in healthy volunteers. Fujimura A; Shiga T; Kumagai Y; Ohashi K; Ebihara A; Kotegawa T J Clin Pharmacol; 1996 May; 36(5):409-13. PubMed ID: 8739019 [TBL] [Abstract][Full Text] [Related]
4. [Effect of a new thromboxane A2 antagonist, S-145, on platelet aggregation]. Kakushi H; Shike T; Uchida K Nihon Yakurigaku Zasshi; 1989 Mar; 93(3):171-8. PubMed ID: 2731807 [TBL] [Abstract][Full Text] [Related]
6. Application of lipid microspheres to prepare a thromboxane A2 receptor antagonist aerosol for inhalation. Takenaga M; Nakagawa T; Igarashi R; Mizushima Y J Drug Target; 1993; 1(4):293-301. PubMed ID: 8069571 [TBL] [Abstract][Full Text] [Related]
8. Different effects of two thromboxane A2/prostaglandin H2 receptor ligands, U46619 and S-145, on rabbit platelets. Nakano T; Hanasaki K; Arita H FEBS Lett; 1988 Jul; 234(2):309-12. PubMed ID: 2968921 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic and pharmacodynamic profiles of vapiprost, a selective, long-lasting thromboxane receptor antagonist, after single and multiple oral administration to healthy volunteers. Uematsu T; Nagashima S; Mizuno A; Hirano K; Nakashima M J Clin Pharmacol; 1991 Sep; 31(9):815-22. PubMed ID: 1839540 [TBL] [Abstract][Full Text] [Related]
10. The cleavage of plasmenylethanolamine by phospholipase A2 appears to be mediated by the low affinity binding site of the TxA2/PGH2 receptor in U46619-stimulated human platelets. Turini ME; Holub BJ Biochim Biophys Acta; 1994 Jun; 1213(1):21-6. PubMed ID: 8011675 [TBL] [Abstract][Full Text] [Related]
11. [Effect of (+)-S-145 calcium salt dihydrate, an orally active antagonist of the thromboxane A2/prostaglandin endoperoxide receptor, on platelet aggregation]. Kakushi H; Shike T; Hayasaki Y; Arita H; Uchida K Nihon Yakurigaku Zasshi; 1991 Aug; 98(2):113-20. PubMed ID: 1916541 [TBL] [Abstract][Full Text] [Related]
12. Characterization of platelet thromboxane A2/prostaglandin H2 receptor by a novel thromboxane receptor antagonist, [3H]S-145. Hanasaki K; Nagasaki T; Arita H Biochem Pharmacol; 1989 Jun; 38(12):2007-17. PubMed ID: 2525906 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic and pharmacodynamic properties of FK070 (KDI-792), a novel thromboxane receptor antagonist/thromboxane synthetase inhibitor, after single and multiple oral administrations to healthy volunteers. Uematsu T; Kosuge K; Umemura K; Nakano M; Terakawa M; Nakashima M J Pharm Pharmacol; 1996 Apr; 48(4):380-5. PubMed ID: 8794987 [TBL] [Abstract][Full Text] [Related]
15. Antiaggregatory activity of 8-epi-prostaglandin F2 alpha and other F-series prostanoids and their binding to thromboxane A2/prostaglandin H2 receptors in human platelets. Yin K; Halushka PV; Yan YT; Wong PY J Pharmacol Exp Ther; 1994 Sep; 270(3):1192-6. PubMed ID: 7932171 [TBL] [Abstract][Full Text] [Related]
16. Antagonistic actions of S-145 on vascular and platelet thromboxane A2 receptors. Mihara S; Hara S; Ueda M; Ide M; Fujimoto M Eur J Pharmacol; 1989 Nov; 171(2-3):179-87. PubMed ID: 2533558 [TBL] [Abstract][Full Text] [Related]
17. Pharmacological characterization of cinnamophilin, a novel dual inhibitor of thromboxane synthase and thromboxane A2 receptor. Yu SM; Wu TS; Teng CM Br J Pharmacol; 1994 Mar; 111(3):906-12. PubMed ID: 8019768 [TBL] [Abstract][Full Text] [Related]
18. Pharmacological profile of BMS 180,291: a potent, long-acting, orally active thromboxane A2/prostaglandin endoperoxide receptor antagonist. Ogletree ML; Harris DN; Schumacher WA; Webb ML; Misra RN J Pharmacol Exp Ther; 1993 Feb; 264(2):570-8. PubMed ID: 8437108 [TBL] [Abstract][Full Text] [Related]
20. Capillary gas chromatographic method for the determination of the thromboxane A2 receptor antagonist S-1452 and its metabolites in human plasma. Okamoto J; Hirai E; Kitagawa T; Matsubara T J Chromatogr; 1992 Nov; 583(1):45-52. PubMed ID: 1484091 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]